awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36163935-9405DF0F-12F2-4DDA-8AC0-5F2887032FAC
Q36163935-9405DF0F-12F2-4DDA-8AC0-5F2887032FAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36163935-9405DF0F-12F2-4DDA-8AC0-5F2887032FAC
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer.
P2860
Q36163935-9405DF0F-12F2-4DDA-8AC0-5F2887032FAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36163935-9405DF0F-12F2-4DDA-8AC0-5F2887032FAC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f6799636113cc4f241ab17dc6ba7fbc4f533478c
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.